PaySign Inc. Reports Record Revenue and Strategic Expansion in Q3 2025

PaySign Inc reported Q3 2025 revenue of $21.6 million, a 41.6% YoY increase, with adjusted EBITDA reaching a record $5 million, up 78%. Patient Affordability revenue surged 142% to $7.9 million, while Plasma revenue rose 12.4% to $12.9 million. Gross profit margin improved by 72 basis points to 56.3%. The company revised its 2025 revenue guidance to $80.5-$81.5 million and expects net income between $7-$8 million and adjusted EBITDA in the range of $19-$20 million.